List of Tables
TABLE 1. HODGKIN LYMPHOMA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ABVD REGIMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY BEACOPP REGIMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY LIPOSOMAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EPACADOSTAT INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY NIVOLUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PEMBROLIZUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADAPTIVE RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY INVOLVED-FIELD RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PROTON RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY BITE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY BRENTUXIMAB VEDOTIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY STAGE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY STAGE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY STAGE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY STAGE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY THIRD LINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY BRENTUXIMAB VEDOTIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY NEXT GENERATION ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY NIVOLUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PEMBROLIZUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY NEXT GENERATION HDAC INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ROMIDEPSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY VORINOSTAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 103. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 104. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 105. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 106. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 107. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 108. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 109. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 110. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 111. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 112. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 113. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 114. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 115. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 116. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 117. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 118. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 119. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 120. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 121. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 123. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 124. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 126. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 127. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 128. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 129. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 130. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 131. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 133. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 134. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 135. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 136. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 137. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 212. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 213. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 214. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 215. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 216. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 217. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 218. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 219. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 220. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 221. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 222. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 223. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 224. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 225. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 226. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 227. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 228. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 229. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 230. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 231. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 232. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 233. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 234. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 235. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 236. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 237. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 238. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 239. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 240. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 241. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 242. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 243. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 244. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 245. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 246. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 247. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 266. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 267. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 268. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 269. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 270. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 271. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 272. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 273. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 274. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 275. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 276. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 277. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 278. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 279. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 280. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 281. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 282. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 283. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 284. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 285. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 286. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 287. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 289. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 290. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 291. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 292. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY ADVANCED STAGE, 2018-2030 (USD MILLION)
TABLE 293. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY EARLY STAGE, 2018-2030 (USD MILLION)
TABLE 294. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2030 (USD MILLION)
TABLE 295. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 296. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 297. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 DIRECTED ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 298. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 299. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 300. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY HISTONE DEACETYLASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 301. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY CD30 TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES HODGKIN LYMPHOMA TREATMENT MARKET SIZE, BY DISEASE ST